Cetuximab therapy in first-line metastatic colorectal cancer and intermittent palliative chemotherapy: review of the COIN trial
EXPERT REVIEW OF ANTICANCER THERAPY (2008)
期刊
EXPERT REVIEW OF ANTICANCER THERAPY
卷 8, 期 8, 页码 1237-1245出版社
TAYLOR & FRANCIS LTD
关键词
类别
资金
- Cancer Research UK [15954] Funding Source: researchfish
作者
我是这篇论文的作者
推荐
Flipside of the Coin: Iron Deficiency and Colorectal Cancer
Aysegul Aksan, Karima Farrag, Sami Aksan, Oliver Schroeder, Juergen Stein
FRONTIERS IN IMMUNOLOGY (2021)
Targeting RAS Mutant Colorectal Cancer with Dual Inhibition of MEK and CDK4/6
Alexey V. Sorokin, Preeti Kanikarla Marie, Lea Bitner, Muddassir Syed, Melanie Woods, Ganiraju Manyam, Lawrence N. Kwong, Benny Johnson, Van K. Morris, Philip Jones, David G. Menter, Michael S. Lee, Scott Kopetz
CANCER RESEARCH (2022)
Clinical and exploratory biomarker findings from the MODUL trial (Cohorts 1, 3 and 4) of biomarker-driven maintenance therapy for metastatic colorectal cancer
Michel Ducreux, Josep Tabernero, Axel Grothey, Dirk Arnold, Peter J. O'Dwyer, Frank Gilberg, Alexander Abbas, Meghna Das Thakur, Hen Prizant, Natsumi Irahara, Anila Tahiri, Hans -Joachim Schmoll, Eric Van Cutsem, Aimery de Gramont
EUROPEAN JOURNAL OF CANCER (2023)
Codon-specific KRAS mutations predict survival benefit of trifluridine/tipiracil in metastatic colorectal cancer
Joris van de Haar, Xuhui Ma, Salo N. Ooft, Pim W. van der Helm, Louisa R. Hoes, Sara Mainardi, David J. Pinato, Kristi Sun, Lisa Salvatore, Giampaolo Tortora, Ina Valeria Zurlo, Silvana Leo, Riccardo Giampieri, Rossana Berardi, Fabio Gelsomino, Valeria Merz, Federica Mazzuca, Lorenzo Antonuzzo, Gerardo Rosati, Chara Stavraka, Paul Ross, Maria Grazia Rodriquenz, Michele Pavarana, Carlo Messina, Timothy Iveson, Federica Zoratto, Anne Thomas, Elisabetta Fenocchio, Margherita Ratti, Ilaria Depetris, Massimiliano Cergnul, Cristina Morelli, Michela Libertini, Alessandro Parisi, Michele De Tursi, Nicoletta Zanaletti, Ornella Garrone, Janet Graham, Raffaella Longarini, Stefania Maria Gobba, Angelica Petrillo, Emiliano Tamburini, Nicla La Verde, Fausto Petrelli, Vincenzo Ricci, Lodewyk F. A. Wessels, Michele Ghidini, Alessio Cortellini, Emile E. Voest, Nicola Valeri
NATURE MEDICINE (2023)
Adagrasib with or without Cetuximab in Colorectal Cancer with Mutated KRAS G12C
Rona Yaeger, Jared Weiss, Meredith S. Pelster, Alexander Spira, Minal Barve, Sai-Hong Ou, Ticiana A. Leal, Tanios S. Bekaii-Saab, Cloud P. Paweletz, Grace A. Heavey, James G. Christensen, Karen Velastegui, Thian Kheoh, Hirak Der-Torossian, Samuel J. Klempner
NEW ENGLAND JOURNAL OF MEDICINE (2023)
Expanded Low Allele Frequency RAS and BRAF V600E Testing in Metastatic Colorectal Cancer as Predictive Biomarkers for Cetuximab in the Randomized CO.17 Trial
Jonathan M. Loree, Anthony Dowers, Dongsheng Tu, Derek J. Jonker, Daniel L. Edelstein, Hannah Quinn, Frank Holtrup, Timothy Price, John R. Zalcberg, Malcolm J. Moore, Christos S. Karapetis, Chris J. O'Callaghan, Paul Waring, Hagen F. Kennecke, Stanley R. Hamilton, Scott Kopetz
CLINICAL CANCER RESEARCH (2021)
Cetuximab and Irinotecan With or Without Bevacizumab in Refractory Metastatic Colorectal Cancer: BOND-3, an ACCRU Network Randomized Clinical Trial
Marla Lipsyc-Sharf, Fang-Shu Ou, Matthew B. Yurgelun, Douglas A. Rubinson, Deborah Schrag, Shaker R. Dakhil, Philip J. Stella, Douglas J. Weckstein, Donald B. Wender, Meredith Faggen, Tyler J. Zemla, Erica N. Heying, Samantha R. Schuetz, Stephanie Noble, Jeffrey A. Meyerhardt, Tanios Bekaii-Saab, Charles S. Fuchs, Kimmie Ng
ONCOLOGIST (2022)
Efficacy and quality of life for FOLFOX/bevacizumab plus /- irinotecan in first-line metastatic colorectal cancer-final results of the AIO CHARTA trial
Hans-Joachim Schmoll, Julia Mann, Fabian Meinert, Benjamin Garlipp, Kersten Borchert, Arndt Vogel, Eray Goekkurt, Ulrich Kaiser, Heinz-Gert Hoeffkes, Joern Ruessel, Stephan Kanzler, Thomas Edelmann, Helmut Forstbauer, Thomas Goehler, Carla Hannig, Bert Hildebrandt, Carsten Roll, Carsten Bokemeyer, Joerg Steighardt, Franziska Cygon, Stefan Ibach, Alexander Stein, Joseph Tintelnot
BRITISH JOURNAL OF CANCER (2023)
Encorafenib: A Review in Metastatic Colorectal Cancer with a BRAF V600E Mutation
Zaina T. Al-Salama
DRUGS (2021)
The optimal first-line treatment for patients with left-sided RAS wild-type metastatic colorectal cancer: Double-drug regimen or triple-drug regimen therapy
Changjing Cai, Qingqing Luo, Yihan Liu, Yinghui Peng, Xiangyang Zhang, Zhaohui Jiang, Ziyang Feng, Yaru Qi, Yan Gao, Yongting Liu, Ping Liu, Yihong Chen, Cao Guo, Hong Shen, Shan Zeng, Ying Han
FRONTIERS IN PHARMACOLOGY (2022)
Effect of Bevacizumab in Combination With Standard Oxaliplatin-Based Regimens in Patients With Metastatic Colorectal Cancer A Randomized Clinical Trial
Antonio Avallone, Maria C. Piccirillo, Guglielmo Nasti, Gerardo Rosati, Chiara Carlomagno, Elena Di Gennaro, Carmela Romano, Fabiana Tatangelo, Vincenza Granata, Antonino Cassata, Lucrezia Silvestro, Alfonso De Stefano, Luigi Aloj, Valeria Vicario, Anna Nappi, Alessandra Leone, Domenico Bilancia, Laura Arenare, Antonella Petrillo, Secondo Lastoria, Ciro Gallo, Gerardo Botti, Paolo Delrio, Francesco Izzo, Franco Perrone, Alfredo Budillon
JAMA NETWORK OPEN (2021)
ModifiedFOLFOXIRIWith or Without Cetuximab as Conversion Therapy in Patients withRAS/BRAFWild-TypeUnresectable Liver Metastases Colorectal Cancer: TheFOCULMMulticenter PhaseIITrial
Huabin Hu, Kun Wang, Meijin Huang, Liang Kang, Wei Wang, Hui Wang, Meng Qiu, Rongbo Lin, Haibo Zhang, Ping Lan, Xiaojian Wu, Guangjian Liu, Yunle Wan, Ming Liu, Zhiyang Zhou, Yan Huang, Fangqian Li, Jianwei Zhang, Yue Cai, Tenghui Ma, Jiaming Zhou, Huaiming Wang, Jiayu Ling, Yonghua Cai, Zehua Wu, Shuangling Luo, Li Ling, Yanhong Deng
ONCOLOGIST (2021)
Randomised controlled trial of intermittent vs continuous energy restriction during chemotherapy for early breast cancer
Michelle Harvie, Mary Pegington, Sacha J. Howell, Nigel Bundred, Phil Foden, Judith Adams, Lee Graves, Alastair Greystoke, Mark P. Mattson, Roy G. Cutler, Julie Williamson, Karen Livingstone, Debbie McMullen, Katharine Sellers, Cheryl Lombardelli, Grace Cooper, Sarah McDiarmid, Anthony Howell
BRITISH JOURNAL OF CANCER (2022)
EGFR-Based Targeted Therapy for Colorectal Cancer-Promises and Challenges
Balakarthikeyan Janani, Mayakrishnan Vijayakumar, Kannappan Priya, Jin Hee Kim, D. S. Prabakaran, Mohammad Shahid, Sameer Al-Ghamdi, Mohammed Alsaidan, Nasraddin Othman Bahakim, Mohammad Hassan Abdelzaher, Thiyagarajan Ramesh
VACCINES (2022)
Maintenance strategies after anti-EGFR-based induction in metastatic colorectal cancer: A systematic review and bayesian network meta-analysis
Luca Mastrantoni, Viria Beccia, Giulia Caira, Giovanni Trovato, Maria Alessandra Calegari, Michele Basso, Lisa Salvatore, Carmelo Pozzo, Giampaolo Tortora, Emilio Bria, Armando Orlandi
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2023)
A Road Map for Designing Phase I Clinical Trials of Radiotherapy-Novel Agent Combinations
Sarah R. Brown, Samantha Hinsley, Emma Hall, Chris Hurt, Richard D. Baird, Martin Forster, Andrew F. Scarsbrook, Richard A. Adams
CLINICAL CANCER RESEARCH (2022)
Trajectories of body weight change and survival among patients with mCRC treated with systemic therapy: Pooled analysis from the ARCAD database
Jan Franko, Jun Yin, Richard A. Adams, John Zalcberg, Jack Fiskum, Eric Van Cutsem, Richard M. Goldberg, Herbert Hurwitz, Carsten Bokemeyer, Fairooz Kabbinavar, Alexandra Curtis, Jeffery Meyers, Benoist Chibaudel, Takayuki Yoshino, Aimery de Gramont, Qian Shi
EUROPEAN JOURNAL OF CANCER (2022)
Evaluating sex as a predictive marker for response to bevacizumab in metastatic colorectal carcinoma: Pooled analysis of 3,369 patients in the ARCAD database
Ofer Margalit, William S. Harmsen, Einat Shacham-Shmueli, Molly M. Voss, Ben Boursi, Anna D. Wagner, Romain Cohen, Curtis L. Olswold, Leonard B. Saltz, Daniel A. Goldstein, Herbert Hurwitz, Niall C. Tebbutt, Fairooz F. Kabbinavar, Richard A. Adams, Benoist Chibaudel, Axel Grothey, Takayuki Yoshino, John Zalcberg, Aimery de Gramont, Qian Shi, Heinz-Josef Lenz
EUROPEAN JOURNAL OF CANCER (2023)
'Eczema shouldn't control you; you should control eczema': qualitative process evaluation of online behavioural interventions to support young people and parents/carers of children with eczema
Kate Greenwell, Katy Sivyer, Laura Howells, Mary Steele, Matthew J. Ridd, Amanda Roberts, Amina Ahmed, Sandra Lawton, Sinead M. Langan, Julie Hooper, Sylvia Wilczynska, Paul Leighton, Gareth Griffiths, Tracey Sach, Paul Little, Hywel C. Williams, Kim S. Thomas, Lucy Yardley, Miriam Santer, Ingrid Muller
BRITISH JOURNAL OF DERMATOLOGY (2023)
Variations in Penile Cancer Management: Results From the Global Society of Rare Genitourinary Tumors Survey
Gagan Prakash, Amandeep Arora, Marco Bandini, Giuseppe Basile, Mahendra Pal, Gareth Griffiths, Robert Cornes, Yao Zhu, Alejandro Rodriguez, Maarten Alberson, Andrea Necchi, Viraj Master, Curtis A. Pettaway, Philippe E. Spiess
CLINICAL GENITOURINARY CANCER (2023)
Effectiveness of spironolactone for women with acne vulgaris (SAFA) in England and Wales: pragmatic, multicentre, phase 3, double blind, randomised controlled trial
Miriam Santer, Megan Lawrence, Susanne Renz, Zina Eminton, Beth Stuart, Tracey H. Sach, Sarah Pyne, Matthew J. Ridd, Nick Francis, Irene Soulsby, Karen Thomas, Natalia Permyakova, Paul Little, Ingrid Muller, Jacqui Nuttall, Gareth Griffiths, Kim S. Thomas, Alison M. Layton
BMJ-BRITISH MEDICAL JOURNAL (2023)
Evaluating atezolizumab in patients with urinary tract squamous cell carcinoma (AURORA): study protocol for a single arm, open-label, multicentre, phase II clinical trial
Simon Crabb, Robin Wickens, Sarah Jane-Bibby, Denise Dunkley, Megan Lawrence, Allen Knight, Robert Jones, Alison Birtle, Robert Huddart, Mark Linch, Jonathan Martin, Adam Coleman, Konstantinos Boukas, Hannah Markham, Gareth Griffiths
BMC CANCER (2023)
A multicentre randomised controlled trial of a guided self-help cognitive behavioural therapy to MANage the impact of hot flushes and night sweats in patients with prostate CANcer undergoing androgen deprivation therapy (MANCAN2)
Simon Crabb, Alannah Morgan, Myra S. S. Hunter, Evgenia Stefanopoulou, Gareth Griffiths, Alison Richardson, Deborah Fenlon, Louisa Fleure, James Raftery, Cherish Boxall, Sam Wilding, Jacqueline Nuttall, Zina Eminton, Emma Tilt, Alice O'Neill, Roger Bacon, Jonathan Martin
TRIALS (2023)
Treating acute exacerbations of COPD with Chinese herbal medicine to aid antibiotic use reduction (Excalibur): a randomised double-blind, placebo-controlled feasibility trial
Merlin L. Willcox, Xiao-Yang Hu, Tom Oliver, Kerensa Thorne, Cherish Boxall, George He, Catherine Simpson, Becci Brotherwood, Alice O'Neil, Robert Waugh, Emma Tilt, Jeanne Trill, Neville Goward, Nick Francis, Michael Thomas, Paul Little, Tom Wilkinson, Jian-Ping Liu, Gareth Griffiths, Michael Moore
FRONTIERS IN PHARMACOLOGY (2023)
Trimodality therapy versus perioperative chemotherapy in the management of locally advanced adenocarcinoma of the oesophagus and oesophagogastric junction (Neo-AEGIS): an open-label, randomised, phase 3 trial
John Reynolds, Shaun R. Preston, Brian O'Neill, Maeve A. Lowery, Lene Baeksgaard, Thomas Crosby, Moya Cunningham, Sinead Cuffe, Gareth Griffiths, Imelda Parker, Signe Lenora Risumlund, Rajarshi Roy, Stephen Falk, George B. Hanna, Frederick R. Bartlett, Alberto Alvarez-Iglesias, Michael P. Achiam, Magnus Nilsson, Guillaume Piessen, Narayanasamy Ravi, Dermot O'Toole, Ciaran Johnston, Raymond S. Mcdermott, Richard C. Turkington, Shajahan Wahed, Sharmila Sothi, Hugo Ford, Martin S. Wadley, Derek Power
LANCET GASTROENTEROLOGY & HEPATOLOGY (2023)
A randomised phase 2a study to investigate the effects of blocking interleukin-33 with tozorakimab in patients hospitalised with COVID-19: ACCORD-2
Tom Wilkinson, Anthony De Soyza, Miles Carroll, James D. Chalmers, Michael G. Crooks, Gareth Griffiths, Manu Shankar-Hari, Ling-Pei Ho, Alex Horsley, Chris Kell, Beatriz Lara, Biswa Mishra, Rachel Moate, Clive Page, Hitesh Pandya, Jason Raw, Fred Reid, Dinesh Saralaya, Ian C. Scott, Salman Siddiqui, Andy Ustianowski, Natalie van Zuydam, Ashley Woodcock, Dave Singh
ERJ OPEN RESEARCH (2023)
Efficacy of early PET-CT directed switch to carboplatin and paclitaxel based definitive chemoradiotherapy in patients with oesophageal cancer who have a poor early response to induction cisplatin and capecitabine in the UK: a multi-centre randomised controlled phase II trial
Somnath Mukherjee, Christopher N. Hurt, Richard Adams, Andrew Bateman, Kevin M. Bradley, Sarah Bridges, Stephen Falk, Gareth Grif, Sarah Gwynne, Christopher M. Jones, PhilipJ. Markham, Tim Maughan, Lisette S. Nixon, Ganesh Radhakrishna, Rajarshi Roy, Simon Schoenbuchner, Hamid Sheikh, Emiliano Spezi, Maria Hawkins, Thomas D. L. Crosby
ECLINICALMEDICINE (2023)
Effectiveness of spironolactone for women with acne vulgaris (SAFA) in England and Wales: pragmatic, multicentre, phase 3, double blind, randomised controlled trial
Miriam Santer, Megan Lawrence, Susanne Renz, Zina Eminton, Beth Stuart, Tracey H. Sach, Sarah Pyne, Matthew J. Ridd, Nick Francis, Irene Soulsby, Karen Thomas, Natalia Permyakova, Paul Little, Ingrid Muller, Jacqui Nuttall, Gareth Griffiths, Kim S. Thomas, Alison M. Layton
BMJ-BRITISH MEDICAL JOURNAL (2023)
RESULTS OF TWO ONLINE RANDOMIZED CONTROLLED TRIALS OF THE ECZEMA CARE ONLINE INTERVENTION FOR PARENTS/CARERS OF CHILDREN AND YOUNG PEOPLE WITH ECZEMA
Kim S. Thomas, Miriam Santer, Ingrid Muller, Taeko Becque, Beth Stuart, Julie Hooper, Tracey H. Sach, Matthew J. Ridd, Amanda Roberts, Amina Ahmed, Mary Steele, Kate Greenwell, Katy Sivyer, Sylvia Wilczynska, Hywel C. Williams, Joanne R. Chalmers, Paul Leighton, Laura M. Howells, Sandra Lawton, Gareth Griffiths, Jacqui Nuttall, Hayden Kirk, Sinead M. Langan, Lucy Yardley, Paul Little
ACTA DERMATO-VENEREOLOGICA (2022)
Olaparib maintenance versus placebo monotherapy in patients with advanced non-small cell lung cancer (PIN): A multicentre, randomised, controlled, phase 2 trial
Dean A. Fennell, Catharine Porter, Jason Lester, Sarah Danson, Fiona Blackhall, Marianne Nicolson, Lisette Nixon, Georgina Gardner, Ann White, Gareth Griffiths, Angela Casbard
ECLINICALMEDICINE (2022)